Balchem (BCPC)

Nasdaq Market Closed

Balchem Corporation is a specialty ingredients company that develops, manufactures and markets products used in nutrition, health, food, animal feed and industrial applications. Rather than competing as a bulk commodity supplier, the company focuses on performance ingredients where formulation expertise, delivery technology and regulatory knowledge are important to customers.

Its largest business is Human Nutrition and Health, which supplies ingredients for food, beverage, dietary supplement and pharmaceutical-related markets. This includes choline nutrients, mineral amino acid chelates and other value-added nutritional systems designed to improve product functionality, stability or health positioning. Balchem is also known for microencapsulation technology, which can protect sensitive ingredients, control release, mask taste or improve handling in finished products.

The Animal Nutrition and Health segment applies similar science to livestock, companion animal and feed markets. Products include choline chloride and chelated minerals, as well as encapsulated nutrients intended to support animal health, productivity and feed efficiency. These offerings serve agricultural customers that need consistent nutrient delivery and specialised formulations.

Balchem’s Specialty Products segment is smaller but distinct, involving the repackaging and distribution of selected gases and chemicals for industrial, medical sterilisation and other technical uses. The company sells mainly in the United States, while also serving international markets.

For investors, BCPC is a specialty chemicals and nutrition stock with exposure to consumer health trends, food innovation and animal agriculture. Its competitive position is supported by ingredient know-how, proprietary processing capabilities and long-standing relationships with manufacturers that require reliable, high-specification inputs.

158.69 USD
140.00 USD
−1.22 (-0.76%)
After-hours

Last updated

Market Cap
5.14B
P/E
32.5
P/FCF
29.2
P/S
4.86
Enterprise Value
5.26B
Sector
Industry
Address
5 PARAGON DRIVE, MONTVALE, NJ, 07645
GlobeNewswire Inc.

Balchem Corporation to Participate in the BNP Paribas Exane Consumer Ingredients & Chemicals Conference on March 11, 2026

25 Feb 2026, 16:00 PM
GlobeNewswire Inc.

Balchem Corporation Announces Quarterly Conference Call for Fourth Quarter and Full Year 2025 Financial Results on February 20, 2026

06 Feb 2026, 16:00 PM
GlobeNewswire Inc.

Balchem Corporation to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 9, 2025

26 Aug 2025, 15:00 PM
GlobeNewswire Inc.

Balchem Corporation Announces Quarterly Conference Call for Second Quarter 2025 Financial Results on July 31, 2025

17 Jul 2025, 15:00 PM
GlobeNewswire Inc.

[Latest] Global Magnesium Supplements Market Size/Share Worth USD 8.94 Billion by 2034 at a 7.43% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

09 Jul 2025, 08:30 AM
GlobeNewswire Inc.

Balchem Corporation to Present at the Wells Fargo Industrials and Materials Conference on June 11, 2025

28 May 2025, 15:00 PM
GlobeNewswire Inc.

Balchem Corporation Announces Quarterly Conference Call for First Quarter 2025 Financial Results on April 24, 2025

11 Apr 2025, 15:00 PM
GlobeNewswire Inc.

Balchem Corporation Reports Fourth Quarter and Full Year 2024 Financial Results

21 Feb 2025, 16:00 PM
GlobeNewswire Inc.

Balchem Corporation Announces Quarterly Conference Call for Fourth Quarter and Full Year 2024 Financial Results on February 21, 2025

07 Feb 2025, 16:00 PM
GlobeNewswire Inc.

Balchem Corporation to Present at CJS Securities New Ideas for the New Year Virtual Conference on January 14, 2025

03 Jan 2025, 16:00 PM
GlobeNewswire Inc.

What the $24.07 Billion Microencapsulation Market Means for Industries - Future Insights

07 Nov 2024, 11:45 AM
GlobeNewswire Inc.

Balchem Corporation to Present at Baird’s 54th Annual Global Industrial Conference on November 13, 2024

01 Nov 2024, 15:00 PM
GlobeNewswire Inc.

Balchem Corporation Reports Third Quarter 2024 Financial Results

25 Oct 2024, 15:00 PM
GlobeNewswire Inc.

Chelated Micronutrient Fertilizer Market is Projected to Grow at a 8.6% CAGR through 2034 | Fact.MR Report

02 Sep 2024, 14:30 PM
GlobeNewswire Inc.

Balchem Corporation to Present at the HC Wainwright & Co. 26th Annual Global Investment Conference on September 9, 2024

23 Aug 2024, 15:00 PM
GlobeNewswire Inc.

Global Cattle Nutrition Market Share Projected to Reach an Unprecedented USD 27 Billion Milestone by 2034, Driven by an Average 5.9% CAGR | Future Market Insights, Inc.

16 Aug 2024, 04:30 AM
GlobeNewswire Inc.

Balchem Corporation to Present at the CJS Securities 24th Annual New Ideas Summer Conference on July 10, 2024

26 Jun 2024, 15:00 PM
Zacks Investment Research

Do Options Traders Know Something About Balchem (BCPC) Stock We Don't?

21 May 2024, 16:52 PM
GlobeNewswire Inc.

Balchem Corporation to Attend the Deutsche Bank Global Consumer Conference on June 4, 2024

21 May 2024, 15:00 PM
GlobeNewswire Inc.

Balchem Corporation Reports First Quarter 2024 Financial Results

03 May 2024, 15:00 PM
Market Cap
5.14B
Enterprise Value
5.26B
P/E
32.5
P/B
4
P/S
4.86
EV / EBITDA
20.14
EV / Sales
4.97
EPS
4.92
Dividend Yield
0.6%
P/FCF
29.2
P/CF
23.34
Free Cash Flow
175.98M
ROE
12.3%
ROA
9.33%
Debt / Equity
0.15
Current Ratio
2.55
Quick Ratio
1.59
Cash
0.48
Avg Volume
209.84K
Fundamentals Snapshot Price
159.91

Income Statement

Line Item 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Revenue 270.71M 263.62M 267.56M 255.47M 250.52M
Gross profit 101.08M 93.9M 95.45M 93.11M 88.17M
Operating income 55.63M 52.29M 54.58M 51.44M 51.02M
EBITDA 68.12M 64.01M 66.13M 62.85M 62.03M
Net income 40.29M 39.23M 40.29M 38.28M 37.05M
Basic EPS 1.26 1.23 1.25 1.18 1.14
Diluted EPS 1.25 1.21 1.24 1.17 1.13

Balance Sheet

Line Item 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Total assets 1.69B 1.69B 1.66B 1.68B 1.62B
Total liabilities 408.63M 428.84M 363.17M 410.33M 408.85M
Total equity 1.29B 1.26B 1.3B 1.27B 1.21B
Cash & equivalents 72.87M 74.57M 65.09M 65.43M 49.9M
Current assets 388.94M 365.61M 343.72M 364.86M 340.24M
Current liabilities 152.54M 176.38M 126.37M 138.14M 139.56M

Cash Flow

Line Item 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Operating cash flow 40.06M 67.28M 65.57M 47.25M 36.46M
Investing cash flow -6.29M -16.42M -14.94M -6.62M -5.91M
Financing cash flow -34.78M -41.25M -50.83M -28.76M -31.97M
Change in cash -1.7M 9.48M -334K 15.53M 386K
Kind Filing Date Link
edgar index SCHEDULE 13G — BALCHEM CORP View Filing
edgar index SCHEDULE 13G — BALCHEM CORP View Filing
edgar index DEF 14A — BALCHEM CORP View Filing
edgar index DEFA14A — BALCHEM CORP View Filing
edgar index 3 — BALCHEM CORP View Filing
form 3 Form 3 — Gilson Erin Leigh View Filing
form 3 Form 3 — Gilson Erin Leigh View Filing
form 3 Form 3 — Gilson Erin Leigh View Filing
form 3 Form 3 — Gilson Erin Leigh View Filing
form 3 Form 3 — Gilson Erin Leigh View Filing
form 3 Form 3 — Gilson Erin Leigh View Filing
form 3 Form 3 — Gilson Erin Leigh View Filing
form 3 Form 3 — Gilson Erin Leigh View Filing
form 3 Form 3 — Gilson Erin Leigh View Filing
form 3 Form 3 — Gilson Erin Leigh View Filing
edgar index SCHEDULE 13G/A — BALCHEM CORP View Filing
edgar index 8-K — BALCHEM CORP View Filing
edgar index 10-K — BALCHEM CORP View Filing
eight k text 8-K — 8-K View Filing
ten k section 10-K — business View Filing
ten k section 10-K — mda View Filing
ten k section 10-K — risk_factors View Filing
edgar index 8-K — BALCHEM CORP View Filing
eight k text 8-K — 8-K View Filing
edgar index 4 — BALCHEM CORP View Filing
edgar index 4 — BALCHEM CORP View Filing
edgar index 4 — BALCHEM CORP View Filing
edgar index 4 — BALCHEM CORP View Filing
edgar index 4 — BALCHEM CORP View Filing
edgar index 4 — BALCHEM CORP View Filing
edgar index 4 — BALCHEM CORP View Filing
edgar index 4 — BALCHEM CORP View Filing
edgar index 4 — BALCHEM CORP View Filing
edgar index 4 — BALCHEM CORP View Filing
edgar index 4 — BALCHEM CORP View Filing
edgar index 4 — BALCHEM CORP View Filing
edgar index 4 — BALCHEM CORP View Filing
edgar index 4 — BALCHEM CORP View Filing
edgar index 4 — BALCHEM CORP View Filing
form 4 Form 4 — Bengtsson Carl Martin View Filing
form 4 Form 4 — Miyata Hatsuki View Filing
form 4 Form 4 — Tignor Michael Brent View Filing
form 4 Form 4 — Boned Frederic View Filing
form 4 Form 4 — Backus William A. View Filing
form 4 Form 4 — Harris Theodore L View Filing
form 4 Form 4 — Reid Martin Luther View Filing
form 4 Form 4 — van Gunsteren Job Leonard View Filing
form 4 Form 4 — Fischer David B View Filing
form 4 Form 4 — Fish Kathleen B View Filing
form 4 Form 4 — Knutson Daniel E View Filing
form 4 Form 4 — Rigaud Olivier View Filing
form 4 Form 4 — VICENTE MONICA View Filing
form 4 Form 4 — Wineinger Matthew David View Filing
form 4 Form 4 — Bengtsson Carl Martin View Filing
form 4 Form 4 — Bengtsson Carl Martin View Filing
form 4 Form 4 — Bengtsson Carl Martin View Filing
form 4 Form 4 — Bengtsson Carl Martin View Filing
form 4 Form 4 — Bengtsson Carl Martin View Filing
form 4 Form 4 — Miyata Hatsuki View Filing
form 4 Form 4 — Miyata Hatsuki View Filing
form 4 Form 4 — Miyata Hatsuki View Filing
form 4 Form 4 — Miyata Hatsuki View Filing
form 4 Form 4 — Miyata Hatsuki View Filing
form 4 Form 4 — Tignor Michael Brent View Filing
form 4 Form 4 — Tignor Michael Brent View Filing
form 4 Form 4 — Tignor Michael Brent View Filing
form 4 Form 4 — Tignor Michael Brent View Filing
form 4 Form 4 — Tignor Michael Brent View Filing
form 4 Form 4 — Boned Frederic View Filing
form 4 Form 4 — Boned Frederic View Filing
form 4 Form 4 — Boned Frederic View Filing
form 4 Form 4 — Boned Frederic View Filing
form 4 Form 4 — Boned Frederic View Filing
form 4 Form 4 — Backus William A. View Filing
form 4 Form 4 — Backus William A. View Filing